Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Simple blood test helps identify patients developing neurotoxic side effects

Simple blood test helps identify patients developing neurotoxic side effects

Researchers find immune-effective ways to destroy cancer cells

Researchers find immune-effective ways to destroy cancer cells

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

Researchers discover a new interferon-gamma receptor signaling pathway

Researchers discover a new interferon-gamma receptor signaling pathway

Study shows new potential target for CAR T cells to inhibit solid tumors

Study shows new potential target for CAR T cells to inhibit solid tumors

Gene expression signatures in lymph node cells play an active role in lymphoma development

Gene expression signatures in lymph node cells play an active role in lymphoma development

CAR-T cell treatment via implantable biotechnology more effective in combating cancer

CAR-T cell treatment via implantable biotechnology more effective in combating cancer

Study uncovers genomic drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma

Study uncovers genomic drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma

Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

CAR T cells produced in vivo using modified mRNA treat cardiac injury

CAR T cells produced in vivo using modified mRNA treat cardiac injury

Researchers discover a crucial and exploitable vulnerability in diffuse large B cell lymphomas

Researchers discover a crucial and exploitable vulnerability in diffuse large B cell lymphomas

Researchers develop new CAR T cells that act as a "micropharmacy"

Researchers develop new CAR T cells that act as a "micropharmacy"

Biochemical signals sent from cell to cell play a key role in deciding their fate

Biochemical signals sent from cell to cell play a key role in deciding their fate

Researchers develop novel technique to monitor remote immune mechanisms

Researchers develop novel technique to monitor remote immune mechanisms

Driving up the immune response at tumor site may help boost immunotherapy

Driving up the immune response at tumor site may help boost immunotherapy

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

Researchers identify a new approach to triggering differentiation in acute myeloid leukemia

Researchers identify a new approach to triggering differentiation in acute myeloid leukemia

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Finding better treatments to eradicate infection caused by H. pylori bacterium

Finding better treatments to eradicate infection caused by H. pylori bacterium